EVE-112 Vaginal Ring
Etonogestrel (ENG) + Ethinyl Estradiol (EE) Vaginal Ring, EVE-112
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Vaginal Ring
-
Intended Duration:
- Short-Acting
- Development Stage: Phase III
- Developer(s)/researcher(s): Evestra, Inc., Gedeon Richter Plc.
Details
- API: Etonogestrel, Ethinyl Estradiol
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Silicone
- Regimen: Undetermined
- MPT: Not Potential MPT
Product Status
No evidence of active development following the completion of Phase III trials. Will be reviewed in 2025 for potential regulatory or commercial progress.
History
2016: Phase III safety, efficacy, and acceptability multi-site trials in Europe